Clinical trial
Alternative Treatment Paradigm for Natalizumab Trial
NCT01710228 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alternative Treatment Paradigm for Natalizumab Trial
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- July 31, 2013
- Completion date
- December 31, 2013
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
multiple sclerosis (ms)